Board of Fermenta Biotech recommends final dividend
28 - May - 2025 12:00 | 5 days ago
Fermenta Biotech announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.
Fermenta Biotech reports consolidated net profit of Rs 34.39 crore in the March 2025 quarter
28 - May - 2025 12:00 | 5 days ago
Net profit of Fermenta Biotech reported to Rs 34.39 crore in the quarter ended March 2025 as against net loss of Rs 6.94 crore during the previous quarter ended March 2024. Sales rose 43.67% to Rs 139.85 crore in the quarter ended March 2025 as against Rs 97.34 crore during the previous quarter ended March 2024.
For the full year,net profit reported to Rs 76.86 crore in the year ended March 2025 as against net loss of Rs 23.06 crore during the previous year ended March 2024. Sales rose 39.87% to Rs 469.48 crore in the year ended March 2025 as against Rs 335.66 crore during the previous year ended March 2024.
Board of Fermenta Biotech recommends final dividend
28 - May - 2025 12:00 | 5 days ago
Fermenta Biotech announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.
Fermenta Biotech reports consolidated net profit of Rs 34.39 crore in the March 2025 quarter
28 - May - 2025 12:00 | 5 days ago
Net profit of Fermenta Biotech reported to Rs 34.39 crore in the quarter ended March 2025 as against net loss of Rs 6.94 crore during the previous quarter ended March 2024. Sales rose 43.67% to Rs 139.85 crore in the quarter ended March 2025 as against Rs 97.34 crore during the previous quarter ended March 2024.
For the full year,net profit reported to Rs 76.86 crore in the year ended March 2025 as against net loss of Rs 23.06 crore during the previous year ended March 2024. Sales rose 39.87% to Rs 469.48 crore in the year ended March 2025 as against Rs 335.66 crore during the previous year ended March 2024.
Board of Fermenta Biotech recommends final dividend
28 - May - 2025 12:00 | 5 days ago
Fermenta Biotech announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.
Fermenta Biotech reports consolidated net profit of Rs 34.39 crore in the March 2025 quarter
28 - May - 2025 12:00 | 5 days ago
Net profit of Fermenta Biotech reported to Rs 34.39 crore in the quarter ended March 2025 as against net loss of Rs 6.94 crore during the previous quarter ended March 2024. Sales rose 43.67% to Rs 139.85 crore in the quarter ended March 2025 as against Rs 97.34 crore during the previous quarter ended March 2024.
For the full year,net profit reported to Rs 76.86 crore in the year ended March 2025 as against net loss of Rs 23.06 crore during the previous year ended March 2024. Sales rose 39.87% to Rs 469.48 crore in the year ended March 2025 as against Rs 335.66 crore during the previous year ended March 2024.
Board of Fermenta Biotech recommends final dividend
28 - May - 2025 12:00 | 5 days ago
Fermenta Biotech announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.
Fermenta Biotech reports consolidated net profit of Rs 34.39 crore in the March 2025 quarter
28 - May - 2025 12:00 | 5 days ago
Net profit of Fermenta Biotech reported to Rs 34.39 crore in the quarter ended March 2025 as against net loss of Rs 6.94 crore during the previous quarter ended March 2024. Sales rose 43.67% to Rs 139.85 crore in the quarter ended March 2025 as against Rs 97.34 crore during the previous quarter ended March 2024.
For the full year,net profit reported to Rs 76.86 crore in the year ended March 2025 as against net loss of Rs 23.06 crore during the previous year ended March 2024. Sales rose 39.87% to Rs 469.48 crore in the year ended March 2025 as against Rs 335.66 crore during the previous year ended March 2024.
Board of Fermenta Biotech recommends final dividend
28 - May - 2025 12:00 | 5 days ago
Fermenta Biotech announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.
Fermenta Biotech reports consolidated net profit of Rs 34.39 crore in the March 2025 quarter
28 - May - 2025 12:00 | 5 days ago
Net profit of Fermenta Biotech reported to Rs 34.39 crore in the quarter ended March 2025 as against net loss of Rs 6.94 crore during the previous quarter ended March 2024. Sales rose 43.67% to Rs 139.85 crore in the quarter ended March 2025 as against Rs 97.34 crore during the previous quarter ended March 2024.
For the full year,net profit reported to Rs 76.86 crore in the year ended March 2025 as against net loss of Rs 23.06 crore during the previous year ended March 2024. Sales rose 39.87% to Rs 469.48 crore in the year ended March 2025 as against Rs 335.66 crore during the previous year ended March 2024.
